Shukla Rajiv's Form 4 filing
Longevity Health Holdings, Inc. (XAGE) · filed Aug 31, 2023
- Accession no.
- 0001213900-23-072813
- Filed
- Aug 31, 2023
- Trade date
- Aug 16-28, 2023
- Filing delay
- 15 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions. Open-market purchases total $30.9K. It was filed 15 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shukla RajivCIK 0001709033 | Director, Officer (Executive Chairman), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 | Common Stock | PPurchaseAcquired | +1,112 | $3.74F1 | +$4,158.88 | 1,112 | Direct | |
| Aug 17, 2023 | Common Stock | PPurchaseAcquired | +100 | $3.54 | +$354 | 1,212 | Direct | |
| Aug 18, 2023 | Common Stock | PPurchaseAcquired | +4,100 | $3.62F2 | +$14,842 | 5,312 | Direct | |
| Aug 21, 2023 | Common Stock | PPurchaseAcquired | +100 | $3.54 | +$354 | 5,412 | Direct | |
| Aug 24, 2023 | Common Stock | PPurchaseAcquired | +500 | $3.50 | +$1,750 | 5,912 | Direct | |
| Aug 25, 2023 | Common Stock | PPurchaseAcquired | +600 | $3.50 | +$2,100 | 6,512 | Direct | |
| Aug 28, 2023 | Common Stock | PPurchaseAcquired | +2,100 | $3.50F3 | +$7,350 | 8,612 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.73 to $3.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.57 to $3.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.43 to $3.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3.
Referenced by the price of 1 transaction in Table I.